Understanding factors that affect treatment differences in multiple myeloma
Modifiable Determinants of Disparities in Multiple Myeloma Treatment Patterns
This study is looking at how things like weight and access to healthcare can affect the treatment of multiple myeloma, especially for Black patients who often face more challenges, and it aims to find ways to make treatment better and more accessible for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11042206 on NIH RePORTER |
What this research studies
This research investigates the various factors that contribute to disparities in treatment for multiple myeloma, particularly focusing on how modifiable elements like obesity and access to care can influence outcomes. The study aims to analyze electronic health records and large datasets to identify patterns and barriers faced by patients, especially within Black communities who are disproportionately affected by this cancer. By engaging with healthcare providers and policymakers, the research seeks to develop strategies to improve treatment access and effectiveness for all patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include Black individuals diagnosed with multiple myeloma, as well as those affected by obesity-related health disparities.
Not a fit: Patients with multiple myeloma who do not belong to the targeted demographic groups or who have other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment access and outcomes for patients with multiple myeloma, particularly among underserved populations.
How similar studies have performed: Previous research has shown success in addressing cancer treatment disparities through targeted interventions, indicating that this approach has potential for meaningful impact.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Gasoyan, Hamlet — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Gasoyan, Hamlet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.